Cumberland
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Visiongain provides revenue forecasts for the period 2017-2027 as well as<br />
qualitative analysis of the global market of stem cell technologies and applications.<br />
The forecast is further segmented by application: Cancer treatment, Cardiovascular,<br />
CNS, Other Disease Area and Non-Therapeutic applications. This report provides<br />
individual revenue forecast to 2027 for selected top products: MSC-100-IV<br />
(Mesoblast), Hearticellgram-AMI (Pharmicell), CardioRel (Reliance Life Sciences),<br />
Osteocel Plus (NuVasive), Trinity Evolution and Elite (Orthofix), CARTISTEM<br />
(MEDIPOST).<br />
Moreover, this report provides analysis of the most promising pipeline therapies in<br />
each therapeutic segment. The 257-page report gives insights on regulatory<br />
environments and developments in the US, Japan, Europe and other leading<br />
countries as well as analysis of what drives and restrains the market. In this brand<br />
new 257-page report you will receive 114 charts– all unavailable elsewhere.<br />
The report Global Stem Cell Technologies and Applications Market 2017-2027:<br />
Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic<br />
Applications report will be of value to anyone who wants to better understand the<br />
Stem Cell Technologies and Applications Market and its various segments. It will be<br />
useful for businesses who wish to better comprehend the part of the market they<br />
are already involved in, or those wishing to enter or expand into a different regional<br />
or technical part of the Stem Cell Technologies and Applications Market.
Change language